National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 58288-58289 [2023-18280]

Download as PDF 58288 Federal Register / Vol. 88, No. 164 / Friday, August 25, 2023 / Notices Review Branch, National Institutes of Health, National Institute on Aging, 7201 Wisconsin Avenue RM: 2W200, Bethesda, MD 20892, 301–496–9374, maurizio.grimaldi@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: August 21, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. [FR Doc. 2023–18368 Filed 8–24–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Integrative Health; Notice of Closed Meeting ddrumheller on DSK120RN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Integrative Health Special Emphasis Panel; Institutional Research Training Grants (IT). Date: September 29, 2023. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Complementary and Integrative Health, Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting). Contact Person: Michael Eric Authement, Ph.D., Scientific Review Officer, Office of Scientific Review, Division of Extramural Activities, NCCIH, NIH, 6707 Democracy Boulevard, Bethesda, MD 20817, michael.authement@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS) Dated: August 21, 2023. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–18281 Filed 8–24–23; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:23 Aug 24, 2023 Jkt 259001 National Institutes of Health National Institute on Aging; Notice of Closed Meeting Name of Committee: National Institute on Aging Special Emphasis Panel; Infrastructure Advancement for Interdisciplinary Elderly Studies Date: November 2, 2023. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Bita Nakhai, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room: 2C212, Bethesda, MD 28092, 301–402–7701, nakhaib@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: August 21, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–18377 Filed 8–24–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Sleep and Alzheimer’s Disease. Date: October 23, 2023. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nesar Uddin Akanda, M.D., Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room: 2E405, Bethesda, MD 28092, (301) 555–1212, nesar.akanda@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: August 21, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–18378 Filed 8–24–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Institutional Training Program (T32) Review. Date: October 18, 2023. Time: 09:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\25AUN1.SGM 25AUN1 ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 88, No. 164 / Friday, August 25, 2023 / Notices Place: National Institutes of Health, Dem II, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20817 (Virtual Meeting). Contact Person: John K. Hayes, Ph.D., Scientific Review Officer National Institute of Biomedical Imaging and Bioengineering National Institutes of Health, 6707 Democracy Blvd., Suite 959, Bethesda, MD 20892, (301) 451–3398 hayesj@mail.nih.gov. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; P41 NCBIB Review E–SEP. Date: October 19, 2023. Time: 10:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Dem II, Suite 920, 6707 Democracy Blvd., Bethesda, MD 20817 (Virtual Meeting). Contact Person: Tianhong Wang, MD, Ph.D., Scientific Review Officer National Institute of Biomedical Imaging and Bioengineering National Institutes of Health, 6707 Democracy Blvd., Suite 959, Bethesda, MD 20892 (301) 435–1189, wangt3@nih.gov. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; P41 NCBIB Review D–SEP. Date: October 25–27, 2023. Time: 09:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Dem II, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20817 (Virtual Meeting). Contact Person: John K. Hayes, Ph.D., Scientific Review Officer National Institute of Biomedical Imaging and Bioengineering National Institutes of Health, 6707 Democracy Blvd., Suite 959, Bethesda, MD 20892, (301) 451–3398, hayesj@mail.nih.gov. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Biomaterials Network RFA (U24) Review. Date: November 2, 2023. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Dem II, Suite 920, 6707 Democracy Blvd., Bethesda, MD 20817 (Virtual Meeting). Contact Person: Tianhong Wang, MD, Ph.D., Scientific Review Officer National Institute of Biomedical Imaging and Bioengineering National Institutes of Health, 6707 Democracy Blvd., Suite 959, Bethesda, MD 20892, (301) 435–1189, wangt3@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health.) Dated: August 21, 2023. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–18280 Filed 8–24–23; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:23 Aug 24, 2023 Jkt 259001 DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2023–0245] National Commercial Fishing Safety Advisory Committee; May 2023 Meetings Coast Guard, DHS. Notice of availability of recommendations and request for comments. AGENCY: ACTION: The Coast Guard announces the availability of recommendations from the National Commercial Fishing Safety Advisory Committee. The Committee met in May 2023 and sent five recommendations to the Secretary of Homeland Security. The U.S. Coast Guard issues this Notice as the mechanism for receiving public comments and requests public comments on the recommendations. DATES: Comments must be submitted on or before November 24, 2023. ADDRESSES: You may submit comments identified by docket number USCG– 2023–0245 using the Federal Decision Making Portal at https:// www.regulations.gov. See the ‘‘Public Participation and Request for Comments’’ portion of the SUPPLEMENTARY INFORMATION section for further instructions on submitting comments. FOR FURTHER INFORMATION CONTACT: For information about this document email questions to Jonathan.G.Wendland@ uscg.mil or call 202–372–1245. SUPPLEMENTARY INFORMATION: SUMMARY: Public Participation and Comments We encourage you to submit comments (or related material) on the committee recommendations. If you submit a comment, please include the docket number for this notice, indicate the specific recommendation to which each comment applies, and provide a reason for each suggestion. Submitting comments. We encourage you to submit comments through the Federal Decision Making Portal at https://www.regulations.gov. To do so, go to https://www.regulations.gov, type USCG–2023–0245 in the search box and click ‘‘Search.’’ Next, look for this document in the Search Results column, and click on it. Then click on the Comment option. If your material cannot be submitted using https:// www.regulations.gov, contact the FOR FURTHER INFORMATION CONTACT section of this document for alternate instructions. Viewing material in docket. To view documents mentioned in this notice as PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 58289 being available in the docket, find the docket as described in the previous paragraph, and then select ‘‘Supporting & Related Material’’ in the Document Type column. Public comments will also be placed in our online docket and can be viewed by following instructions on the https://www.regulations.gov Frequently Asked Questions web page. We review all comments received, but we may choose not to post off-topic, inappropriate, or duplicate comments that we receive. Personal information. We accept anonymous comments. Comments we post to https://www.regulations.gov will include any personal information you have provided. You may wish to view the Privacy & Security Notice and the User Notice, which are both available on the homepage of https:// www.regulations.gov, and DHS’s eRulemaking System of Records notice (85 FR 14226, March 11, 2020). Discussion The National Commercial Fishing Safety Advisory Committee is authorized by section 601 of the Frank LoBiondo Coast Guard Authorization Act of 2018, (Pub. L. 115–282, 132 Stat. 4190), and is codified in 46 U.S.C. 15102. The Committee operates under the provisions of the Federal Advisory Committee Act and 46 U.S.C. 15109. The National Commercial Fishing Safety Advisory Committee provides advice and recommendations to the Secretary of Homeland Security through the Commandant of the U.S. Coast Guard, on matters relating to the safe operation of vessels. Additionally, the Committee will review regulations proposed under chapter 45 of Title 46 of U.S. Code (during preparation of the regulations) and review marine casualties and investigations of vessels covered by chapter 45 of Title 46 U.S. Code and make recommendations to the Secretary to improve safety and reduce vessel casualties. The National Commercial Fishing Safety Advisory Committee (the committee) met from May 23, 2023 to May 25, 2023 (88 FR 26585).1 The U.S. Coast Guard issued 3 tasks to the committee, and the committee sent 5 recommendations to the Secretary based on those tasks. As required by 46 U.S.C. 15109(j)(3)(B), the Coast Guard is establishing a mechanism for the submission of public comments on these recommendations. • Task #01–23 tasked the committee with reviewing 10 Marine Casualty investigation cases related to Personal 1 The U.S. Coast Guard gave public notice of this meeting on May 1, 2023. 88 FR 26585. E:\FR\FM\25AUN1.SGM 25AUN1

Agencies

[Federal Register Volume 88, Number 164 (Friday, August 25, 2023)]
[Notices]
[Pages 58288-58289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18280]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings of the 
National Institute of Biomedical Imaging and Bioengineering Special 
Emphasis Panel.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; Institutional Training 
Program (T32) Review.
    Date: October 18, 2023.
    Time: 09:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 58289]]

    Place: National Institutes of Health, Dem II, Suite 920, 6707 
Democracy Boulevard, Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: John K. Hayes, Ph.D., Scientific Review Officer 
National Institute of Biomedical Imaging and Bioengineering National 
Institutes of Health, 6707 Democracy Blvd., Suite 959, Bethesda, MD 
20892, (301) 451-3398 [email protected].

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; P41 NCBIB Review E-SEP.
    Date: October 19, 2023.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Dem II, Suite 920, 6707 
Democracy Blvd., Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Tianhong Wang, MD, Ph.D., Scientific Review 
Officer National Institute of Biomedical Imaging and Bioengineering 
National Institutes of Health, 6707 Democracy Blvd., Suite 959, 
Bethesda, MD 20892 (301) 435-1189, [email protected].

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; P41 NCBIB Review D-SEP.
    Date: October 25-27, 2023.
    Time: 09:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Dem II, Suite 920, 6707 
Democracy Boulevard, Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: John K. Hayes, Ph.D., Scientific Review Officer 
National Institute of Biomedical Imaging and Bioengineering National 
Institutes of Health, 6707 Democracy Blvd., Suite 959, Bethesda, MD 
20892, (301) 451-3398, [email protected].

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; Biomaterials Network RFA 
(U24) Review.
    Date: November 2, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Dem II, Suite 920, 6707 
Democracy Blvd., Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Tianhong Wang, MD, Ph.D., Scientific Review 
Officer National Institute of Biomedical Imaging and Bioengineering 
National Institutes of Health, 6707 Democracy Blvd., Suite 959, 
Bethesda, MD 20892, (301) 435-1189, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, 
National Institute of Biomedical Imaging and Bioengineering, 
National Institutes of Health.)

    Dated: August 21, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-18280 Filed 8-24-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.